Dual anti-platelet therapy remains a cornerstone of the treatment for coronary artery disease. When choosing a second anti-platelet, ticagrelor remains a principal agent after the recent PLATO trial ...
La Gerche said studies show bradycardia, defined in the study as a heart rate ≤ 40 beats/min, and sinus pauses of 2-3 seconds ...
Researchers have identified bradycardia-an abnormally low heart rate–as a symptom of xylazine-opioid overdose.